Prof Axel Heidenreich
Advertisement
Articles by Prof Axel Heidenreich
In this first installment of a 2-part interview, guideline chair professor Axel Heidenreich outlines key updates in the management of testicular cancer, with a strong focus on deintensification.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves belzutifan plus lenvatinib for advanced clear cell renal cell carcinoma
2
After curative-intent treatment, prostate cancer recurrence is still an unmet need
3
FDA grants priority review to perioperative durvalumab plus enfortumab vedotin in MIBC
4
Sandip Prasad, MD, on patient selection for chemoablation in LG-IR-NMIBC
5